These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 16491417)
1. Nondiabetic consequences of obesity on kidney. Srivastava T Pediatr Nephrol; 2006 Apr; 21(4):463-70. PubMed ID: 16491417 [TBL] [Abstract][Full Text] [Related]
2. [Influence of obesity in children on kidney]. Roszkowska-Blaim M Przegl Lek; 2006; 63 Suppl 3():25-8. PubMed ID: 16898481 [TBL] [Abstract][Full Text] [Related]
3. Low glomerular density with glomerulomegaly in obesity-related glomerulopathy. Tsuboi N; Utsunomiya Y; Kanzaki G; Koike K; Ikegami M; Kawamura T; Hosoya T Clin J Am Soc Nephrol; 2012 May; 7(5):735-41. PubMed ID: 22403274 [TBL] [Abstract][Full Text] [Related]
4. Structural renal changes in obesity and diabetes. Amann K; Benz K Semin Nephrol; 2013 Jan; 33(1):23-33. PubMed ID: 23374891 [TBL] [Abstract][Full Text] [Related]
5. Renal disease in obesity: the need for greater attention. Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023 [TBL] [Abstract][Full Text] [Related]
6. [Obesity and chronic kidney disease]. Bondar' IA; Klimontov VV; Simakova AI Ter Arkh; 2011; 83(6):66-70. PubMed ID: 21786579 [TBL] [Abstract][Full Text] [Related]
7. [Overweight and obesity--risk factors in the development and progression of renal disease]. Sebeková K; Klassen A; Bahner U; Heidland A Vnitr Lek; 2004 Jul; 50(7):544-9. PubMed ID: 15323263 [TBL] [Abstract][Full Text] [Related]
8. Obesity and chronic kidney disease. Eknoyan G Nefrologia; 2011; 31(4):397-403. PubMed ID: 21623393 [TBL] [Abstract][Full Text] [Related]
12. The Fatty Kidney: Obesity and Renal Disease. Praga M; Morales E Nephron; 2017; 136(4):273-276. PubMed ID: 27414023 [TBL] [Abstract][Full Text] [Related]
13. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Rüster C; Wolf G Semin Nephrol; 2013 Jan; 33(1):44-53. PubMed ID: 23374893 [TBL] [Abstract][Full Text] [Related]
14. Evidence for the use of glomerulomegaly as a surrogate marker of glomerular damage and for alpha-linolenic acid-rich oils in the treatment of early obesity-related glomerulopathy in a diet-induced rodent model of obesity. Caligiuri SP; Blydt-Hansen T; Love K; Grégoire M; Taylor CG; Zahradka P; Aukema HM Appl Physiol Nutr Metab; 2014 Aug; 39(8):951-9. PubMed ID: 24927777 [TBL] [Abstract][Full Text] [Related]
15. Overweight, obesity and metabolic alterations in chronic kidney disease. Zoccali C Prilozi; 2009 Dec; 30(2):17-31. PubMed ID: 20087247 [TBL] [Abstract][Full Text] [Related]
16. Time to abandon microalbuminuria? Ruggenenti P; Remuzzi G Kidney Int; 2006 Oct; 70(7):1214-22. PubMed ID: 16871239 [TBL] [Abstract][Full Text] [Related]
18. Podocyte lesions in patients with obesity-related glomerulopathy. Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996 [TBL] [Abstract][Full Text] [Related]
19. Diabetic nephropathy: early detection, prevention and management. Maher JF Am Fam Physician; 1992 Apr; 45(4):1661-8. PubMed ID: 1558042 [TBL] [Abstract][Full Text] [Related]
20. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes. Nosadini R; Brocco E Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]